US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MapLight Therapeutics, Inc.

9.68

-0.5100-5.00%

Volume:79.82K

Turnover:787.84K

Market Cap:537.97M

PE:-1.91

High:10.17

Open:10.16

Low:9.65

Close:10.19

52wk High:40.43

52wk Low:9.10

Shares:55.58M

Float Shares:19.23M

Volume Ratio:0.66

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.0580

EPS(LYR):-18.5643

ROE:-111.55%

ROA:-67.11%

PB:1.54

PE(LYR):-0.52

Loading ...

Overview Company News Filings

MapLight Therapeutics Currently Down 11 Consecutive Days, on Pace for Record Losing Streak

MapLight Therapeutics on Track for Record Losing Streak

Maplight Therapeutics General Counsel Kristopher Hanson Sells 16,509 Shares for $192,654.03

MapLight Therapeutics files to sell 13.18M shares of common stock for holders

Maplight Therapeutics - Prospectus Covers Resale of up to 13,181,055 Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS

MapLight Therapeutics to Present at Morgan Stanley Global Healthcare Conference

MapLight Therapeutics price target lowered to $43 from $45 at Needham

Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares

Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics price target lowered to $21 from $24 at Canaccord

Analysts’ Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate

Benzinga Earnings

MapLight Q2 FY26 Net Loss Widens to $60.19 Million; R&D Expenses Rise to $53.44 Million

Press Release: MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

MapLight Therapeutics Prices USD 150 Million PIPE at USD 11.38 a Share

Maplight Therapeutics Announces $150 Million Private Placement Financing

THOMSON REUTERS

MapLight Therapeutics Announces $150 Million Private Placement Financing

MapLight Therapeutics Price Target Cut to $13.00/Share from $52.00 by UBS

UBS Downgrades MapLight Therapeutics to Neutral From Buy, Adjusts PT to $13 From $52

MT Newswires Live

Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/MPLT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MPLT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":9.68,"timestamp":1790870055757,"preClose":10.19,"halted":0,"volume":79815,"delay":0,"changeRate":-0.050049067713444535,"floatShares":19234500,"shares":55575700,"eps":-5.058,"marketStatus":"Trading","change":-0.51,"latestTime":"10-01 11:54:18 EDT","open":10.16,"high":10.165,"low":9.65,"amount":787838.779965,"amplitude":0.05054,"askPrice":9.72,"askSize":57,"bidPrice":9.68,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-5.058,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":10.19,"preHourTrading":{"tag":"盘前","latestPrice":10.15,"preClose":10.19,"latestTime":"09:29 EDT","volume":969,"amount":9874.010193,"timestamp":1790861399999,"change":-0.04,"changeRate":-0.003925,"amplitude":0.089303},"postHourTrading":{"tag":"盘后","latestPrice":10.19,"preClose":10.19,"latestTime":"19:30 EDT","volume":2199,"amount":22407.81,"timestamp":1790811003237,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.661244,"impliedVol":1.2371,"impliedVolPercentile":0.5402},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MPLT\",,,,,undefined,":{"symbol":"MPLT","floatShares":19234500,"roa":"-67.11%","roe":"-111.55%","lyrEps":-18.564313,"volumeRatio":0.661244,"shares":55575700,"dividePrice":0,"high":10.165,"amplitude":0.05054,"preClose":10.19,"low":9.65,"week52Low":9.1,"pbRate":"1.54","week52High":40.43,"institutionHeld":0,"latestPrice":9.68,"committee":0.55642,"eps":-5.058,"divideRate":0,"volume":79815,"delay":0,"ttmEps":-5.058,"open":10.16,"prevYearClose":17.565,"prevWeekClose":10.46,"prevMonthClose":10.19,"prevQuarterClose":10.19,"fiveDayClose":10.76,"twentyDayClose":13.06,"sixtyDayClose":38.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MPLT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"MPLT","fiscalQuarterEnding":"2026/06","expectedEps":-1.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.32},{"market":"US","date":"2026-05-14","symbol":"MPLT","fiscalQuarterEnding":"2026/03","expectedEps":-0.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-1.34},{"market":"US","date":"2026-03-26","symbol":"MPLT","fiscalQuarterEnding":"2025/12","expectedEps":-1.05,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-2.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MPLT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MPLT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3571,"buy":0.5,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":14,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MPLT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MPLT","date":"2026-09-30","current":-1.926236,"percent":0.969697,"low":-9.047313,"twenty":-8.024668,"median":-7.290024,"eighty":-5.032174,"high":-2.251599,"avg":-6.529903,"sd":1.983813,"marketCap":564093547},"quantilePoints":[{"date":"2025-10-31","current":-8.673514,"twenty":-8.310978,"median":-7.61973,"eighty":-7.489746,"marketCap":801692922},{"date":"2025-11-07","current":-7.620605,"twenty":-8.035178,"median":-7.644213,"eighty":-7.545137,"marketCap":704372551},{"date":"2025-11-14","current":-6.742394,"twenty":-7.98511,"median":-7.554503,"eighty":-7.23627,"marketCap":623199506},{"date":"2025-11-21","current":-6.274959,"twenty":-7.73109,"median":-7.394197,"eighty":-6.810384,"marketCap":579994498},{"date":"2025-11-28","current":-6.435493,"twenty":-7.639491,"median":-7.190943,"eighty":-6.54881,"marketCap":594832581},{"date":"2025-12-05","current":-7.783335,"twenty":-7.714027,"median":-7.115398,"eighty":-6.435493,"marketCap":800383679},{"date":"2025-12-12","current":-8.528142,"twenty":-7.986054,"median":-7.394197,"eighty":-6.45249,"marketCap":876974375},{"date":"2025-12-19","current":-8.462361,"twenty":-8.266224,"median":-7.554503,"eighty":-6.54881,"marketCap":870209954},{"date":"2025-12-26","current":-7.689969,"twenty":-8.289163,"median":-7.620605,"eighty":-6.624355,"marketCap":790782566},{"date":"2026-01-02","current":-7.454432,"twenty":-8.20424,"median":-7.61973,"eighty":-6.670627,"marketCap":766561577},{"date":"2026-01-09","current":-7.295285,"twenty":-8.111814,"median":-7.53948,"eighty":-6.75706,"marketCap":750196044},{"date":"2026-01-16","current":-7.84275,"twenty":-8.074467,"median":-7.609335,"eighty":-6.818055,"marketCap":806493478},{"date":"2026-01-23","current":-7.885189,"twenty":-7.999774,"median":-7.554503,"eighty":-6.827382,"marketCap":810857620},{"date":"2026-01-30","current":-7.885189,"twenty":-8.004018,"median":-7.620167,"eighty":-6.893484,"marketCap":810857620},{"date":"2026-02-06","current":-6.662942,"twenty":-7.999774,"median":-7.609335,"eighty":-6.893484,"marketCap":685170325},{"date":"2026-02-13","current":-7.308017,"twenty":-7.988887,"median":-7.547968,"eighty":-7.020967,"marketCap":751505286},{"date":"2026-02-20","current":-7.605091,"twenty":-7.988887,"median":-7.532944,"eighty":-7.096512,"marketCap":782054282},{"date":"2026-02-27","current":-7.392895,"twenty":-7.98511,"median":-7.541432,"eighty":-7.116712,"marketCap":760233571},{"date":"2026-03-06","current":-7.622066,"twenty":-7.966096,"median":-7.547968,"eighty":-7.127226,"marketCap":783799939},{"date":"2026-03-13","current":-8.122848,"twenty":-7.991064,"median":-7.592359,"eighty":-7.180699,"marketCap":835296817},{"date":"2026-03-20","current":-7.422602,"twenty":-8.000623,"median":-7.590237,"eighty":-7.203617,"marketCap":763288470},{"date":"2026-03-27","current":-5.207658,"twenty":-7.991064,"median":-7.583871,"eighty":-7.203617,"marketCap":839224545},{"date":"2026-04-02","current":-5.640953,"twenty":-7.988887,"median":-7.541432,"eighty":-7.116384,"marketCap":909050820},{"date":"2026-04-10","current":-7.964495,"twenty":-7.986054,"median":-7.516065,"eighty":-6.867043,"marketCap":1283494221},{"date":"2026-04-17","current":-7.720766,"twenty":-7.972363,"median":-7.507481,"eighty":-6.969974,"marketCap":1244216941},{"date":"2026-04-24","current":-7.883252,"twenty":-7.986054,"median":-7.516065,"eighty":-7.077626,"marketCap":1270401794},{"date":"2026-05-01","current":-8.966125,"twenty":-8.009111,"median":-7.554503,"eighty":-7.116384,"marketCap":1444908993},{"date":"2026-05-08","current":-8.214962,"twenty":-8.052399,"median":-7.590237,"eighty":-7.121808,"marketCap":1323857628},{"date":"2026-05-15","current":-6.658186,"twenty":-8.072823,"median":-7.605091,"eighty":-7.121808,"marketCap":1328174850},{"date":"2026-05-22","current":-6.655912,"twenty":-8.056678,"median":-7.585993,"eighty":-6.867043,"marketCap":1327721393},{"date":"2026-05-29","current":-6.769572,"twenty":-8.053247,"median":-7.547968,"eighty":-6.753265,"marketCap":1350394231},{"date":"2026-06-05","current":-6.842314,"twenty":-8.050011,"median":-7.507675,"eighty":-6.705014,"marketCap":1364904847},{"date":"2026-06-12","current":-6.899144,"twenty":-8.036085,"median":-7.484139,"eighty":-6.662816,"marketCap":1376241266},{"date":"2026-06-18","current":-6.64,"twenty":-8.014204,"median":-7.474515,"eighty":-6.654094,"marketCap":1324547195},{"date":"2026-06-26","current":-7.265128,"twenty":-8.003169,"median":-7.454432,"eighty":-6.652876,"marketCap":1449247804},{"date":"2026-07-02","current":-8.201684,"twenty":-8.01675,"median":-7.469285,"eighty":-6.653639,"marketCap":1636071990},{"date":"2026-07-10","current":-9.047313,"twenty":-8.054945,"median":-7.484139,"eighty":-6.655912,"marketCap":1804757904},{"date":"2026-07-17","current":-8.460828,"twenty":-8.122848,"median":-7.507675,"eighty":-6.658186,"marketCap":1687766060},{"date":"2026-07-24","current":-8.008463,"twenty":-8.137812,"median":-7.547968,"eighty":-6.662732,"marketCap":1597528165},{"date":"2026-07-31","current":-3.189291,"twenty":-8.129236,"median":-7.516065,"eighty":-6.653448,"marketCap":636199834},{"date":"2026-08-07","current":-3.018802,"twenty":-8.123697,"median":-7.486261,"eighty":-6.561799,"marketCap":602190577},{"date":"2026-08-14","current":-2.692276,"twenty":-8.099082,"median":-7.474515,"eighty":-6.526795,"marketCap":537055294},{"date":"2026-08-21","current":-2.266153,"twenty":-8.09314,"median":-7.454432,"eighty":-6.435493,"marketCap":520823053},{"date":"2026-08-28","current":-3.032366,"twenty":-8.06605,"median":-7.420317,"eighty":-6.349031,"marketCap":696919516},{"date":"2026-09-04","current":-3.177455,"twenty":-8.055812,"median":-7.370362,"eighty":-6.26295,"marketCap":730264947},{"date":"2026-09-11","current":-3.333426,"twenty":-8.052399,"median":-7.329236,"eighty":-6.1487,"marketCap":766111286},{"date":"2026-09-18","current":-2.737351,"twenty":-8.049665,"median":-7.312639,"eighty":-6.03858,"marketCap":629117139},{"date":"2026-09-25","current":-2.601934,"twenty":-8.035579,"median":-7.308017,"eighty":-5.386392,"marketCap":597994736},{"date":"2026-09-30","current":-2.454427,"twenty":-8.024668,"median":-7.290024,"eighty":-5.032174,"marketCap":564093547}],"updateTime":1790865187159},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MPLT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671241891","title":"MapLight Therapeutics Currently Down 11 Consecutive Days, on Pace for Record Losing Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2671241891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671241891?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:54","pubTimestamp":1790704440,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.  is currently at $10.17, down $0.28 or 2.68%--Would be lowest close since July 27, 2026, when it closed at $9.90--On pace for largest percent decrease since Sept. 25, 2026, when it fell 2.79%--Currently down 12 of the past 13 days--Currently down 11 consecutive days; down 22.66% over this period--Longest losing streak on record --Worst 11 day stretch since the 11 days ending Aug. 13, 2026, when it fell 22.9%--Down 21.59% month-to-date; on pace for worst month since July 2026, when it fell 63.67%--Down 42.1% year-to-date--Down 74.45% from its all-time closing high of $39.80 on July 9, 2026--Down 74.45% from its 52-week closing high of $39.80 on July 9, 2026--Up 2.68% from its 52-week closing low of $9.91 on July 27, 2026--Traded as low as $10.14--Down 2.97% at today's intraday lowAll data as of 1:52:33 PM ETSource: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670349247","title":"MapLight Therapeutics on Track for Record Losing Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2670349247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670349247?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:56","pubTimestamp":1790268960,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.  is currently at $10.64, down $0.13 or 1.16%--Would be lowest close since July 27, 2026, when it closed at $9.90--On pace for largest percent decrease since Sept. 18, 2026, when it fell 3.53%--Currently down nine of the past 10 days--Currently down eight consecutive days; down 19.05% over this period--Longest losing streak on record --Worst eight-day stretch since the eight days ending Aug. 5, 2026, when it fell 64.66%--Down 17.93% month-to-date; on pace for worst month since July 2026, when it fell 63.67%--Down 39.4% year-to-date--Down 73.25% from its all-time closing high of $39.80 on July 9, 2026--Down 73.25% from its 52-week closing high of $39.80 on July 9, 2026--Up 7.47% from its 52-week closing low of $9.91 on July 27, 2026--Traded as low as $10.16--Down 5.66% at today's intraday lowAll data as of 12:53:47 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668497338","title":"Maplight Therapeutics General Counsel Kristopher Hanson Sells 16,509 Shares for $192,654.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2668497338","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668497338?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:15","pubTimestamp":1789762544,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics General Counsel Kristopher Hanson sells 16,509 shares for $192,654.03Maplight Therapeutics General Counsel Kristopher Hanson sold 16,509 voting common shares on Sept. 16, 2026 at","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1zPZyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maplight Therapeutics General Counsel Kristopher Hanson Sells 16,509 Shares for $192,654.03","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666055890","title":"MapLight Therapeutics files to sell 13.18M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666055890","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666055890?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:30","pubTimestamp":1788989410,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 13.18M shares of common stock. The company is not ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-files-to-sell-13-18m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-files-to-sell-13-18m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558653","title":"Maplight Therapeutics - Prospectus Covers Resale of up to 13,181,055 Common Shares by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558653","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558653?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:29","pubTimestamp":1788989380,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45116O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666873665","title":"MapLight Therapeutics to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666873665","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666873665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:02","pubTimestamp":1788951775,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics to present at Morgan Stanley Global Healthcare ConferenceMapLight Therapeutics management will present at Morgan Stanley’s 24th Annual Global Healthcare Conference in New York on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLPGlTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","MPLT","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663229077","title":"MapLight Therapeutics price target lowered to $43 from $45 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2663229077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663229077?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:15","pubTimestamp":1788174932,"startTime":"0","endTime":"0","summary":"Needham lowered the firm’s price target on MapLight Therapeutics (MPLT) to $43 from $45 and keeps a Buy rating on the shares. The firm is updating ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-43-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-43-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490191","title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490191","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490191?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:56","pubTimestamp":1787093780,"startTime":"0","endTime":"0","summary":"Catalyst4 acquires $50.07 million of MapLight Therapeutics common sharesCatalyst4 increased its Maplight Therapeutics stake with a purchase of 4.4 million voting common shares at USD 11.38 each.Benefi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbk2NP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248003","title":"Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248003","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248003?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:57","pubTimestamp":1786971453,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on MapLight Therapeutics, Inc., with a price target of $21.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074172","title":"MapLight Therapeutics price target lowered to $21 from $24 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074172?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:18","pubTimestamp":1786886308,"startTime":"0","endTime":"0","summary":"Canaccord analyst Sumant Kulkarni lowered the firm’s price target on MapLight Therapeutics (MPLT) to $21 from $24 and keeps a Buy rating on the sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140382","title":"Analysts’ Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140382?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:40","pubTimestamp":1786718411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Solv Energy (MWH) and MapLight Therapeutics, Inc. (MPLT) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4129","NA","MWH","MPLT","BK4141","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616715","title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616715","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616715?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:27","pubTimestamp":1786652832,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/MPLT","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162232","title":"MapLight Q2 FY26 Net Loss Widens to $60.19 Million; R&D Expenses Rise to $53.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162232","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162232?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:11","pubTimestamp":1786651916,"startTime":"0","endTime":"0","summary":"MapLight Q2 FY26 net loss widens to $60.19 million; R&D expenses rise to $53.44 millionMapLight Therapeutics posted a Q2 net loss of $60.19 million, widening from $29.85 million a year earlier.R&D exp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL64hVdL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","MPLT","BK4139","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162663","title":"Press Release: MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162663?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"trial of ML-007C-MA in adults with schizophrenia experiencing an acute. exacerbation of psychosis. The trial met its primary endpoint, with the. 210/3 mg twice-daily dose demonstrating a statistically significant and. clinically meaningful reduction in PANSS total score compared with. -- ML-007C-MA also demonstrated improvement on a prespecified. impairment and significant separation on key secondary endpoints,including CGI-S and the PANSS Marder positive factor.-- ML-007C-MA was generally well tolerated, with no serious or drug-related. severe adverse events and low rates of GI-related discontinuations. Its. clinical profile, including simple initiation, 99% of patients reaching","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564222.USD","STBQ","LU0234570918.USD","LU1623119135.USD","ADP","IE0005OL40V9.USD","LU0672654240.SGD","FNCL","IYG","VFH","FDFF","LU0006306889.USD","MPLT","LU0868494617.USD","IE00BQXX3C00.GBP","XLF","LU2764262908.HKD","LU1989764748.USD","BK4559","BK4585","LATR","LU1236620750.USD","LU1145028129.USD","LU0174119429.USD","IE000F7OJYX1.SGD","BK4613","IE00B1XK9C88.USD","LU2347655073.USD","IE00BJJMRX11.SGD","UYG","LU1084165304.USD","LU2360107671.USD","LU2404859667.USD","IPAY","LU0061474705.USD","LU1316542783.SGD","IE00B775H168.HKD","LU2361044865.SGD","LU2462157665.USD","MA","LU0965509010.AUD","IE000WAW04H5.SGD","LU2417539215.USD","LU0353189763.USD","IE00BYQQ9H92.USD","LU0056508442.USD","LU0942090050.USD","LU2023250504.SGD","ASD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157908","title":"MapLight Therapeutics Prices USD 150 Million PIPE at USD 11.38 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157908","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157908?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626622,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics prices USD 150 million PIPE at USD 11.38 a shareMapLight Therapeutics priced a USD 150 million PIPE of unregistered equity securities, led by new and existing institutional inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3K2fQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","LU2210149790.SGD","IE00BN0W2T93.GBP","MPLT","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","BCDF","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4139","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","BK4112","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659979157","title":"Maplight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659979157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659979157?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2BY2WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157434","title":"MapLight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157434","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157434?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and BOSTON, Aug.  13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344584/0/en/maplight-therapeutics-announces-150-million-private-placement-financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956143","title":"MapLight Therapeutics Price Target Cut to $13.00/Share from $52.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956143","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956143?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:00","pubTimestamp":1786392000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MPLT/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658793933","title":"UBS Downgrades MapLight Therapeutics to Neutral From Buy, Adjusts PT to $13 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2658793933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658793933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:43","pubTimestamp":1786362188,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics (MPLT) has an average rating of Buy and mean price target of $32.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657195595","title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2657195595","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657195595?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:40","pubTimestamp":1785890431,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics CSO Lillie James Woodruff sells 22,082 shares for $276,908.28Maplight Therapeutics Chief Scientific Officer Lillie James Woodruff sold 22,082 shares of voting common stock on Aug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL2JY0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":120,"code":"91000000","status":"200"}]}}